Table 3 Clinical–epidemiological characteristics of the population with CKD according to the vital status
Characteristics | Vital status | p Value | |
|---|---|---|---|
Dead (n = 60) | Alive (n = 283) | ||
Age (years)* | 81.9 (10.1) | 77.5 (12.2) | < 0.01 |
Sex** | 0.01 | ||
Female | 14 (11.0) | 113 (89.0) | |
Male | 46 (21.3) | 170 (78.7) | |
Hypertension** | 0.52 | ||
Yes | 41 (18.5) | 181 (81.5) | |
No | 19 (15.7) | 102 (84.3) | |
Diabetes** | 0.06 | ||
Yes | 24 (23.3) | 79 (76.7) | |
No | 36 (15.0) | 204 (85.0) | |
CKD stage** | < 0.01 | ||
1,2 | 2 (9.1) | 20 (90.9) | |
3a–3b | 51 (16.4) | 260 (83.6) | |
4–5 | 7 (70.0) | 3 (30.0) | |
Laboratory profile | |||
Serum creatinine (mg/dL)* | 1.6 (0.9) | 1.4 (0.3) | < 0.01 |
eGFR (ml/min/1.73 m2)* | 45.0 (11.5) | 47.9 (10.2) | 0.05 |
Glucose (mg/dL)*** | 91.5 (84–104) | 90 (82–103) | 0.55 |
Total protein (g/dL)* | 7.2 (1.0) | 7.3 (0.6) | 0.27 |
Albumin (g/dL)* | 4.0 (0.4) | 4.2 (0.4) | < 0.01 |
AST (U/L)*** | 23 (19–27) | 23 (19–28) | 0.70 |
ALT (U/L)*** | 17.5 (14–23) | 18.0 (13–24) | 0.96 |
Total bilirubin (mg/dL)*** | 0.6 (0.4–0.8) | 0.6 (0.5–0.8) | 0.63 |
Alkaline phosphatase (U/L)*** | 101 (80–132) | 101 (82–127) | 0.71 |
Globulin (g/dL)* | 3.2 (0.6) | 3.1 (0.8) | 0.66 |
Hemoglobin (g/dL)* | 11.7 (1.9) | 12.3 (1.6) | 0.03 |
Platelets (K/uL)* | 225 (107.8) | 240 (76.1) | 0.20 |
Neutrophils (K/uL)* | 4.1 (1.6) | 3.9 (1.5) | 0.49 |